
Liquidity, historical trends, and peer comparisons.
According to Abivax S.A.’s latest financial reports and current stock price. The company's current Current Ratio is 5.97. This represents a change of 37.97% compared to the average of 4.32 of the last 4 quarters.
The mean historical Current Ratio of Abivax S.A. over the last ten years is 3.54. The current 5.97 Current Ratio has changed 68.51% with respect to the historical average. Over the past ten years (40 quarters), ABVX's Current Ratio was at its highest in in the December 2015 quarter at 11.59. The Current Ratio was at its lowest in in the June 2013 quarter at 0.
Average
3.54
Median
2.42
Minimum
0.94
Maximum
8.75
Discovering the peaks and valleys of Abivax S.A. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 375.78%
Maximum Annual Current Ratio = 8.75
Minimum Annual Increase = -60.49%
Minimum Annual Current Ratio = 0.94
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 8.75 | 375.78% |
| 2024 | 1.84 | -54.97% |
| 2023 | 4.08 | 336.01% |
| 2022 | 0.94 | -60.49% |
| 2021 | 2.37 | 25.87% |
| 2020 | 1.88 | 36.48% |
| 2019 | 1.38 | -44.15% |
| 2018 | 2.47 | -35.69% |
| 2017 | 3.84 | -51.06% |
| 2016 | 7.85 | -32.27% |
The current Current Ratio of Abivax S.A. (ABVX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
4.89
5-year avg
3.59
10-year avg
3.54
Abivax S.A.’s Current Ratio is less than Nurix Therapeutics, Inc. (8.44), greater than AnaptysBio, Inc. (5.61), less than Spyre Therapeutics, Inc. (18.53), greater than Aclaris Therapeutics, Inc. (3.46), greater than Annexon, Inc. (5.53), greater than Inventiva S.A. (3.81), less than Immix Biopharma, Inc. (25.13), less than Syndax Pharmaceuticals, Inc. (6.77), greater than Arcus Biosciences, Inc. (3.82), less than Avalo Therapeutics, Inc. (19.31),
| Company | Current Ratio | Market cap |
|---|---|---|
| 8.44 | $2.80B | |
| 5.61 | $1.42B | |
| 18.53 | $8.67B | |
| 3.46 | $565.89M | |
| 5.53 | $644.72M | |
| 3.81 | $190.35M | |
| 25.13 | $606.02M | |
| 6.77 | $1.17B | |
| 3.82 | $2.24B | |
| 19.31 | $380.24M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Abivax S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Abivax S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Abivax S.A.'s Current Ratio?
How is the Current Ratio calculated for Abivax S.A. (ABVX)?
What is the highest Current Ratio for Abivax S.A. (ABVX)?
What is the 3-year average Current Ratio for Abivax S.A. (ABVX)?
What is the 5-year average Current Ratio for Abivax S.A. (ABVX)?
How does the current Current Ratio for Abivax S.A. (ABVX) compare to its historical average?